COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

Video Credit: ANI
Published on May 27, 2020 - Duration: 01:43s

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

While commenting on World Health Organisation's decision to temporarily suspend clinical trials of hydroxychloroquine, Director General of Council of Scientific and Industrial Research (CSIR), Shekhar Mande supported ICMR's judgement on HCQ trials.

"I'm sure WHO will take consider the call in coming time.

We should trust ICMR's judgement, they are well qualified.

Hence, we should continue," said Shekhar Mande while talking to ANI.


You are here

Related videos from verified sources

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct 03:14
Video credit: HT Digital Content - Published on May 30, 2020 

WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG 01:36
Video credit: ANI - Published on May 29, 2020 

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug 01:26
Video credit: ANI - Published on May 26, 2020 

You might like